Revelation Pharma Elevates Nancy Fingerhut to VP of Quality Assurance and Regulatory Affairs

Revelation Pharma Appoints Nancy Fingerhut as VP of Quality Assurance and Regulatory Affairs

Revelation Pharma, a notable entity in the realm of compounding pharmacies, has announced the promotion of Nancy Fingerhut to the position of Vice President of Quality Assurance and Regulatory Affairs. This strategic move aims to bolster the company’s commitment to excellence in patient safety and compliance throughout its expansive network of 503A and 503B compounding pharmacies.

Nancy Fingerhut, a seasoned regulatory expert, brings over two decades of experience in regulatory compliance to her new role. Her journey with Revelation Pharma commenced through the acquisition of Lee Silsby Compounding Pharmacy, where she previously served as Chief Operating Officer. Fingerhut’s extensive knowledge and leadership capabilities in navigating the compliance landscape are anticipated to play a pivotal role in enforcing the highest standards of quality assurance across Revelation Pharma’s facilities.

In her new capacity, Fingerhut is dedicated to steering regulatory initiatives that maintain stringent adherence to both state and federal regulations. She emphasizes the importance of ethical practices and patient safety as foundational elements throughout her career. “At Revelation, I have the privilege of collaborating with leaders who reflect a profound commitment to regulatory excellence. Our mission is centered on unwavering quality for our patients,” she remarked, highlighting her enthusiasm for the upcoming challenges.

This leadership change is hailed as a remarkable opportunity for Revelation Pharma to further underscore its reputation for quality and compliance in the pharmaceutical industry. According to Shawn Hodges, the CEO of Revelation Pharma, “We couldn’t be more excited to have Nancy step into this new role. Her extensive regulatory expertise and unwavering dedication to quality make her the ideal leader to guide our entire national network. With Nancy at the helm, Revelation Pharma will continue to set the standard of excellence for regulatory responsibility.”

Under Fingerhut’s guidance, Revelation Pharma aims to enhance its ongoing expansion strategy, which focuses on acquiring and developing reputable compounding pharmacies across the nation. This vision aligns with the company’s broader goal of providing innovative, high-quality, and personalized pharmaceutical preparations and services to meet the diverse needs of patients and healthcare providers.

Revelation Pharma operates with a comprehensive therapeutic scope, addressing various health concerns such as Women's Health, Men's Health, Dermatology, Anti-Infective treatments, Weight Management, and Animal Health, among others. Their businesses encapsulate a diverse range of services, including Revelation Wholesale, Penile Rehab Protocol, and more.

This strategic elevation of leadership underscores Revelation Pharma’s dedication to excellence in service delivery and quality assurance, sealing its position as a frontrunner in the evolving landscape of pharmaceutical care. As the company continues to pave the way in regulatory compliance and patient safety, stakeholders and patients alike will look forward to the advancements under Nancy Fingerhut’s stewardship.

For more information about Revelation Pharma and its services, visit their website and follow them on social media platforms.